|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1996; 28:948-958 © 1996 by the American College of Cardiology Foundation |
Department of Internal Medicine I (Cardiology), University Hospital, Rheinisch-Westfalische-Technische Hochschule Aachen, Germany.
OBJECTIVES: This study sought to evaluate an imaging approach using technetium-99m sestamibi scintigraphy and positron emission tomography with fluorine-18 fluorodeoxyglucose for assessment of myocardial viability proved by serial quantitative left ventricular angiography. Furthermore, the influence of successful long-term revascularization on functional recovery was studied. BACKGROUND: Previous studies using positron emission tomography of myocardial perfusion and metabolism have demonstrated accurate identification of myocardial viability. However, most of these studies used a qualitative or semiquantitative wall motion analysis approach. METHODS: Nuclear imaging with semiquantitative analysis of tracer uptake was performed in 193 patients with regional wall motion abnormalities. Regions were categorized as normal, viable with perfusion/metabolism mismatch, viable without mismatch (intermediate) and scar. Seventy-two of 103 patients with subsequent revascularization underwent follow-up angiography. In 52 of 72 patients, changes in regional wall motion were measured by the centerline method from serial angiography. RESULTS: Wall motion improved in mismatch regions from -2.2 +/- 1.0 to -1.1 +/- 1.4 SD (p < 0.001). In contrast, regions with an intermediate pattern and those with scar did not improve. Restenosis or graft occlusion influenced functional outcome because regions with preoperative mismatch and successful long-term revascularization improved at follow-up (from -2.3 +/- 1.0 to -0.8 +/- 1.4 SD, p < 0.001), whereas wall motion did not change with recurrent hypoperfusion. Metabolic imaging added diagnostic information, particularly in regions with mild and moderate perfusion defects. CONCLUSIONS: This imaging approach allows detection of viability in regions with myocardial dysfunction. Wall motion benefits most in myocardium with perfusion/metabolism mismatch and successful long-term revascularization.
This article has been cited by other articles:
|
|
 |
|
  H. P. Kuhl, C. S.A. Lipke, G. A. Krombach, M. Katoh, T. F. Battenberg, B. Nowak, N. Heussen, A. Buecker, and W. M. Schaefer Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol Eur. Heart J., April 1, 2006; 27(7): 846 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Schwarz, R. Gupta, T. P. Diep, B. Nowak, S. Kostin, B. Grohmann, B. F. Uretsky, and J. Schaper Carvedilol Improves Myocardial Contractility Compared With Metoprolol in Patients With Chronic Hibernating Myocardium After Revascularization Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2005; 10(3): 181 - 190. [Abstract] [PDF]
|
|
|
|
|
|
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Schaefer, C. S.A. Lipke, B. Nowak, H.-J. Kaiser, P. Reinartz, A. Buecker, G. A. Krombach, U. Buell, and H. P. Kuhl Validation of QGS and 4D-MSPECT for Quantification of Left Ventricular Volumes and Ejection Fraction from Gated 18F-FDG PET: Comparison with Cardiac MRI J. Nucl. Med., January 1, 2004; 45(1): 74 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Schaefer, B. Nowak, H.-J. Kaiser, K.-C. Koch, S. Block, J. vom Dahl, and U. Buell Comparison of Microsphere-Equivalent Blood Flow (15O-Water PET) and Relative Perfusion (99mTc-Tetrofosmin SPECT) in Myocardium Showing Metabolism-Perfusion Mismatch J. Nucl. Med., January 1, 2003; 44(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hoffmann, E. Altiok, B. Nowak, N. Heussen, H. Kuhl, H.-J.u. Kaiser, U. Bull, and P. Hanrath Strain rate measurement by doppler echocardiography allows improvedassessment of myocardial viability inpatients with depressed left ventricular function J. Am. Coll. Cardiol., February 6, 2002; 39(3): 443 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.V. Cokkinos Can metabolic manipulation reverse myocardial dysfunction? Eur. Heart J., December 1, 2001; 22(23): 2138 - 2139. [PDF]
|
|
|
|
 |
|
 J.J. Bax, A. Elhendy, E. Boersma, and D. Poldermans Evaluation of patients with chronic ischaemic left ventricular dysfunction - assessment of tissue viability Eur. Heart J. Suppl., September 1, 2001; 3(suppl_F): F11 - F14. [Abstract] [PDF]
|
|
|
|
|
|
X. Zhang, X.-J. Liu, Q. Wu, R. Shi, R. Gao, Y. Liu, S. Hu, Y. Tian, S. Guo, and W. Fang Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial 99mTc-MIBI SPECT and 18F-FDG PET J. Nucl. Med., August 1, 2001; 42(8): 1166 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Koch, J. vom Dahl, M. Wenderdel, B. Nowak, W. M. Schaefer, A. Sasse, C. Stellbrink, U. Buell, and P. Hanrath Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization J. Am. Coll. Cardiol., July 1, 2001; 38(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Fath-Ordoubadi, K J Beatt, N Spyrou, and P G Camici Efficacy of coronary angioplasty for the treatment of hibernating myocardium Heart, August 1, 1999; 82(2): 210 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nakano, J.-D. Lee, H. Shimizu, T. Tsuchida, Y. Yonekura, Y. Ishii, and T. Ueda Reciprocal ST-segment depression associated with exercise-induced ST-segment elevation indicates residual viability after myocardial infarction J. Am. Coll. Cardiol., March 1, 1999; 33(3): 620 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Schwarz, T. Reffelmann, F. Schoendube, B. Herrmanns, R. Chakupurakal, H. Doerge, T. Schuetz, M. Foresti, B. J. Messmer, P. W. Radke, et al. Hypoxic Hypoperfusion Fails to Induce Myocardial Hibernation in Anesthetized Swine Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(4): 235 - 247. [Abstract] [PDF]
|
|
|
|
|
|
I. Matsunari, G. Boning, S. I. Ziegler, S. G. Nekolla, J. C. Stollfuss, I. Kosa, E. P. Ficaro, and M. Schwaiger Attenuation-corrected 99mTc-tetrofosmin single-photon emission computed tomography in the detection of viable myocardium: comparison with positron emission tomography using 18F-fluorodeoxyglucose J. Am. Coll. Cardiol., October 1, 1998; 32(4): 927 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Kloner, R. Bolli, E. Marban, L. Reinlib, and E. Braunwald Medical and Cellular Implications of Stunning, Hibernation, and Preconditioning : An NHLBI Workshop Circulation, May 19, 1998; 97(18): 1848 - 1867. [Full Text] [PDF]
|
|
|
|
|
|
J. E. Udelson Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction Circulation, March 10, 1998; 97(9): 833 - 838. [Full Text] [PDF]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
